Sarah J. Morgan
- Endocrinology top 5%
- Vibrio bacteria research studies 4
-
- Thyroid Disorders and Treatments 7
- Growth Hormone and Insulin-like Growth Factors 4
- Molecular Medicine top 10%
-
- Receptor Mechanisms and Signaling 7
- Protein Kinase Regulation and GTPase Signaling 3
-
- Cystic Fibrosis Research Advances 8
-
- Pediatric health and respiratory diseases 4
-
- Neuropeptides and Animal Physiology 3
- Co-authors
- Marvin C. GershengornPeter J. ParkerAnthony D. SmithSusanne NeumannEric S. KrukonisChristine C. KriegerPradeep K. SinghBernice Marcus‐Samuels
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)PLoS ONE (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Sarah J. Morgan
35 papers receiving 881 citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Endocrinology 106
- Endocrinology, Diabetes and Metabolism 188
- Molecular Medicine 43
- Molecular Biology 400
- Pathology and Forensic Medicine 102
Countries citing papers authored by Sarah J. Morgan
This map shows the geographic impact of Sarah J. Morgan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah J. Morgan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah J. Morgan more than expected).
Fields of papers citing papers by Sarah J. Morgan
This network shows the impact of papers produced by Sarah J. Morgan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah J. Morgan. The network helps show where Sarah J. Morgan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah J. Morgan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 15 | |
| 4 | 2023 | 1 | |
| 5 | Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persistbreakdown → | 2023 | 106 |
| 6 | 2022 | 4 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 10 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 43 | |
| 11 | 2019 | 34 | |
| 12 | 2019 | 12 | |
| 13 | 2018 | 19 | |
| 14 | 2017 | 16 | |
| 15 | 2017 | 26 | |
| 16 | 2016 | 11 | |
| 17 | 2016 | 15 | |
| 18 | 2011 | 26 | |
| 19 | 1994 | 1 | |
| 20 | 1990 | 116 |
About Sarah J. Morgan
Sarah J. Morgan is a scholar working on Endocrinology, Emergency Medical Services and Endocrinology, Diabetes and Metabolism, having authored 37 papers that have together received 889 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (8 papers), Thyroid Disorders and Treatments (7 papers), Receptor Mechanisms and Signaling (7 papers), Vibrio bacteria research studies (4 papers), Pediatric health and respiratory diseases (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Neuropeptides and Animal Physiology (3 papers). The work is most often cited by research in Endocrinology (106 citations), Endocrinology, Diabetes and Metabolism (188 citations) and Molecular Medicine (43 citations). Sarah J. Morgan has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Marvin C. Gershengorn, Peter J. Parker, Anthony D. Smith, Susanne Neumann, Eric S. Krukonis, Christine C. Krieger, Pradeep K. Singh, Bernice Marcus‐Samuels, George J. Kahaly and Raymond B. Penn. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.